ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Diagnostic criteria"

  • Abstract Number: 157 • 2014 ACR/ARHP Annual Meeting

    Can We Diagnose Acute Gout without Joint Aspiration? Results of a Prospective Study of 112 Patients Presenting with Acute Arthritis

    Pascal Zufferey, Roxana Valcov, Isabelle Fabreguet, Alexandre Dumusc and Alexander So, DAL, RHU/CHUV, Lausanne, Switzerland

    Background/Purpose The gold standard for the diagnosis of acute MSU induced arthritis is crystal identification by microscopy after joint aspiration. Alternative diagnostic tools that have…
  • Abstract Number: 2914 • 2014 ACR/ARHP Annual Meeting

    The Clinical and Radiographic Course of Early Undifferentiated Arthritis Under Treatment Is Not Dependent on the Amount of Erosions at Diagnosis. Results from the Swiss Prospective Observational Cohort

    Ruediger Mueller1, Toni Kaegi2, Sarah Haile3 and Johannes von Kempis4, 1Rheumatology, Kantonsspital St. Gallen, St. Gallen, Switzerland, 2Division of Rheumatology, Kantonsspital St. Gallen, St. Gallen, Switzerland, 3Division of Biostatistics, Institute for Social and Preventive Medicine,, University of Zurich, Switzerland, Zurich, Switzerland, 4Rheumatology, St. Gallen Hospital, CH- 9007 St.Gallen, Switzerland

    Background/Purpose To analyse whether early arthritis patients who do not fulfil the ACR/EULAR 2010 classification criteria for rheumatoid arthritis (RA) have a different course of…
  • Abstract Number: 2779 • 2014 ACR/ARHP Annual Meeting

    Systemic Inflammatory and Autoimmune Manifestations Associated with Myelodysplastic Syndrome: A French Multicenter Retrospective Study

    Arsene Mekinian1, Eric Grignano1, Thorsten Braun2, Olivier Decaux3, Eric Liozon4, Nathalie Costedoat-Chalumeau5, Jean Emmanuel Kahn6, Mohamed Hamidou7, Geraldine Falgarone8, Olivier Lortholary9, Sophie Park10, Zahir Amoura11, A. Mathian12, Bruno Gombert13, Christian Rose14, Xavier Puechal15, David Launay16, Guillaume Denis17, Bertrand Lioger18, Anne Laure Buchdaul19, Sophie georgin Lavialle20, Francois Montestruc21, Mohammed Omouri22, Julien Rossignol23, Jean Marc Ziza24, Pascal Cathebras25, Serge Madaule26, Benoit de Wazières27, Nathalie Morel15, Sebastien Trouillet28, Loic Raffray29, Yoland Schoindre30, Eric Toussirot31, jean Charles Piette32, Claude Gardin2, Lionel Ades33, Pierre Fenaux33 and Olivier Fain34, 1Internal Medicine, DHUi2B Saint Antoine Hospital, paris, France, 2Haematology department Avicenne Hospital, bobigny, France, 3Department of Internal Medicine, Rennes University Hospital, Rennes, France, 4INTERNAL MEDICINE, DIJON, France, 5Internal Medicine, Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 6Internal medicine Hopital Foch, PARIS, France, 7CHU Hôtel Dieu, Nantes, Nantes, France, 8Rheumatology department Avicenne Hospital INSERM 1125, bobigny, France, 9Service de maladies infectieuses, Hôpital Necker-Enfants malades, AP-HP, Paris, France, 10Haematology Department, Grenoble University Hospital, grenoble, France, 11Internal medicine 2, French National Reference Center for Systemic Lupus and Antiphospholipid Syndrome, Pitié-Salpêtrière Hospital (AP-HP), Paris, France, 12Internal Medecine Department, Pitie-Salpetriere Hospital, Paris, France, 13Internal Medicine, La Rochelle hospital, La Rochelle, France, 14haematology, lille, France, 15Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, 16Service de médecine interne, Centre National de Référence de la Sclérodermie Systémique, Hôpital Claude Huriez, CHRU Lille, Lille, France, 17Internal Medicine, Rochefoucault hospital, Rochefoucault, France, 18INTERNAL MEDICINE, tours, France, 19Internal Medicine, Douai hospital, Douai, France, 20Internal Medicine Department Tenon Hospital, paris, France, 21exystat, PARis, France, 22Rheumatology Department Romilly Hospital, romilly, France, 23haematology, paris, France, 24Hopital Croix-Saint-Simon, Paris Cedex 20, France, 25Internal Medicine, University Hospital St Etienne, St Etienne, France, 26Medecine interne, Chg, Albi, France, 27Department of Internal Medicine and Gerontology, Hôpital Universitaire Carémeau, Nîmes, France, Nimes, France, 28INTERNAL MEDICINE, aurillac, France, 29INTERNAL MEDICINE, bordeaux, France, 30DHU 2iB Internal Medicine Referal Center for Autoimmune diseases Pitie Hospital, PARIS, France, 31Clinical Investigation Centre Biotheraoy CIC 1431, Rheumatology Department, Univesity Hospital, besancon, France, 32INTERNAL MEDICINE, PARIS, France, 33Haematology department Saint Louis Hospital, paris, France, 34Hôpital Saint Antoine, DHU i2B, Service de Médecine Interne, paris, France

    Background/Purpose: To describe characteristics, treatment and outcome of patients with systemic inflammatory or autoimmune diseases (SAID) and myelodysplastic syndrome (MDS).Methods: For this retrospective study, a…
  • Abstract Number: 2786 • 2013 ACR/ARHP Annual Meeting

    Review Of The Expert Panel Methodology In The Diagnostic and Classification Criteria For Vasculitis Study: A Pilot Study

    Cristina Ponte1, Anthea Craven2, Joanna Robson2, Peter C. Grayson3, Ravi Suppiah4, Richard A. Watts5, Peter A. Merkel6 and Raashid A. Luqmani2, 1Rheumatology and Metabolic Bone Diseases Department, Hospital de Santa Maria, CHLN and Rheumatology Research Unit, Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal, 2Nuffield Department of Orthopaedics Rheumatology and Musculoskeletal Sciences, Botnar Research Centre, University of Oxford, Oxford, United Kingdom, 3Section of Rheumatology & the Clinical Epidemiology Unit, Boston University School of Medicine, Vasculitis Center, Boston, MA, 4Department of Rheumatology, Auckland District Health Board, Auckland, New Zealand, 5Rheumatology Department Ipswich Hospital and University of East Anglia, Ipswich, United Kingdom, 6Division of Rheumatology, Vasculitis Center, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: The Diagnostic and Classification Criteria for Vasculitis (DCVAS) Study is a multinational observational study to develop diagnostic criteria and to update classification criteria for…
  • Abstract Number: 2144 • 2012 ACR/ARHP Annual Meeting

    Early RA Patients Fulfilling the New 2010 ACR/EULAR Criteria, Display Better Clinical Responses to DMARD Therapy but Have Higher Radiographic Damage Progression Than Patients with Early RA Not Fulfilling the 2010 ACR/EULAR Criteria

    Ruediger Mueller1, Toni Kaegi1, Axel Finckh2 and Johannes von Kempis1, 1Rheumatology, Kantonsspital St. Gallen, St. Gallen, Switzerland, 2Rheumatology, Geneva University Hospitals, Geneva 14, Switzerland

    Background/Purpose: New ACR/EULAR criteria for the classification of rheumatoid arthritis (RA) were recently proposed. The aim of this analysis was to examine the impact of…
  • Abstract Number: 2112 • 2012 ACR/ARHP Annual Meeting

    Combination of Magnetic Resonance Imaging (MRI)-Proven Osteitis with 2010 RA Classification Criteria Improves the Diagnostic Probability of Rheumatoid Arthritis (RA)

    Mami Tamai1, Yoshikazu Nakashima1, Takahisa Suzuki1, Yoshiro Horai2, Akitomo Okada2, Junko Kita2, Shin-ya Kawashiri3, Naoki Iwamoto2, Kunihiro Ichinose4, Kazuhiko Arima2, Hideki Nakamura5, Tomoki Origuchi6, Masataka Uetani7, Kiyoshi Aoyagi8, Katsumi Eguchi9 and Atsushi Kawakami3, 1Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 2Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 3Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 4Department of Immunology and Rheumatology, Unit of Translational Medicine, Department of Immunology and Rheumatology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 5Department of Immunology and Rheumatology, Nagasaki University, Nagasaki, Japan, 6Department of Health Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 7Department of Radiology and Radiation Research, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 8Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan, 9Sasebo City General Hospital, Sasebo, Nagasaki, Japan

    Background/Purpose: In the articles of 2010 rheumatoid arthritis (RA) classification criteria, it is stated that additional evidence of joint injury from other imaging techniques such…
  • Abstract Number: 2025 • 2012 ACR/ARHP Annual Meeting

    Clinical Characteristics and Therapy Response in a Large Single-Centre Cohort of Patients with Periodic Fever with Aphtous Stomatitis, Pharyngitis and Cervical Adenitis Syndrome

    Francesca Ricci1, Antonella Meini1, Lucio Verdoni2, Laura Dotta1, Marta Bolis2, Marco Berlucchi3, Gianfranco Savoldi4 and Marco Cattalini2, 1Pediatric Clinic, University of Brescia and Spedali Civili di Brescia, Pediatric Immunology and Rheumatology Unit, Brescia, Italy, 2Pediatric Clinic, Spedali Civili di Brescia and University of Brescia, Pediatric Immunology and Rheumatology Unit, Brescia, Italy, 3Spedali Civili di Brescia, Department of Pediatric Otorhinolaryngology, Brescia, Italy, 4Spedali Civili di Brescia, Angelo Nocivelli Institute of Molecular Medicine, Brescia, Italy

    Background/Purpose: PFAPA (Period Fever with Aphtous stomatitis, Pharyngitis and cervical Adenitis), is a periodic syndrome described for the first time in 1987 by Marshall et…
  • Abstract Number: 1875 • 2012 ACR/ARHP Annual Meeting

    A Patient and Physician Survey of Impact and Management of Fibromyalgia Across Latin America and Europe

    Patricia Clark, Unidad de Epidemilogia Clinica, Hospital Infantil de México Federico Gómez, Mexico City, Mexico

    Background/Purpose: Differences in healthcare practices around the world have been reported; however any impact on management of chronic conditions is often unclear. We surveyed patients…
  • Abstract Number: 555 • 2012 ACR/ARHP Annual Meeting

    Performances of the ASAS Axial Spondyloarthritis Criteria for Diagnosis and Classification Purposes in Patients Visiting a Rheumatologist Because of Chronic Back Pain: The Declic Study

    Anna Moltó1, Simon Paternotte2, Denis Comet3, Cécile Hacquard-Bouder4, Martin Rudwaleit5, Pascal Claudepierre6, Désirée van der Heijde7 and Maxime Dougados1, 1Rheumatology B Department, Paris-Descartes University, APHP, Cochin Hospital, Paris, France, 2Rheumatology Department, Paris- Descartes University, Cochin hospital, Paris, France, 3Axonal, Nanterre, France, 4Abbott France, Rungis, France, 5Endokrinologikum Berlin, Berlin, Germany, 6Rheumatology, Henri Mondor Teaching Hospital, AP-HP, Créteil, France, 7Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: To evaluate the performances at diagnosis (sensitivity [Se], specificity [Spe], positive and negative predictive values) and study visit (classification purpose) of the ASAS criteria…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology